2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.56+$0.02 (+1.30%)
Price as of Oct 22, 2026 7:32 PM EDT- $44.7MMarket Cap
- -9.55%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.56+$0.02 (+1.30%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.54 | ||
Change | +$0.01 (+0.63%) | ||
Open | $1.58 | ||
High | $1.63 | ||
Low | $1.52 | ||
Previous Close | $1.61 | ||
Volume | 220,703 | ||
30-Day Average Volume | 293,113 | ||
1-Week Change | 0.63% | ||
1-Month Change | -29.69% | ||
1-Year Change | -9.55% | ||
3-Year Change | -77.69% | ||
5-Year Change | -91.61% | ||
Fundamentals | |||
Shares Outstanding | 27.8M | ||
Total Assets | $26.8M | ||
Market Cap | $44.7M | ||
Enterprise Value | $26.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.3M | ||
Net Working Capital | $17.9M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -32 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue